Gene: KRTCAP3
Official Full Name: keratinocyte associated protein 3provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37946 | KRTCAP3 Knockout cell line (HeLa) | Human | KRTCAP3 | 1:3~1:6 | Negative | Online Inquiry |
KO37947 | KRTCAP3 Knockout cell line (HCT 116) | Human | KRTCAP3 | 1:2~1:4 | Negative | Online Inquiry |
KO37948 | KRTCAP3 Knockout cell line (HEK293) | Human | KRTCAP3 | 1:3~1:6 | Negative | Online Inquiry |
KRTCAP3 Gene Knockout Cell Lines encompass genetically modified cell lines that have undergone targeted gene disruption of the KRTCAP3 gene, which is implicated in various cellular processes including keratinocyte function and hair follicle development. These cell lines serve as a valuable tool for investigating the biological roles of KRTCAP3 in cell differentiation, signaling pathways, and disease models.
The primary mechanism of action involves the CRISPR/Cas9 technology or similar gene-editing approaches, which enable precise manipulation of the genome. By knocking out the KRTCAP3 gene, researchers can elucidate its contribution to cellular behavior and physiology. This mechanism allows for a more nuanced understanding of its role in skin biology and related disorders, making these cell lines critical for both basic and translational research.
Scientifically, KRTCAP3 gene knockout cell lines are significant in various applications, including the study of dermatological diseases, regenerative medicine, and cancer biology. They offer insights into pathways that could be targeted for therapeutic interventions and contribute to the discovery of novel biomarkers. Their relevance extends to testing the efficacy of potential treatments in a controlled environment that mimics real cellular behaviors.
Compared to standard cell lines that retain the intact KRTCAP3 gene, our knockout variants provide a distinctive advantage. They eliminate confounding factors, allowing for unambiguous interpretations of experimental results. Researchers can achieve higher specificity in their studies, ultimately leading to more reliable data. Furthermore, the versatility of these cell lines enables them to be optimized for high-throughput screening and drug validation processes.
Investing in KRTCAP3 Gene Knockout Cell Lines brings substantial value to researchers and clinicians alike. The precision they offer facilitates groundbreaking research that can directly translate into therapeutic advancements, enhancing the potential for impactful discoveries in skin pathologies and hair disorders.
Our company specializes in developing high-quality biological products, and we leverage our expertise in genetic engineering to provide tools that meet the evolving needs of the research community. This commitment ensures that our customers receive innovative products backed by robust scientific validation, empowering them to achieve their research goals effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.